Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qinghai Lake Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the research, development, and large-scale production of licorice-derived active pharmaceutical ingredients (APIs). Located in the Qinghai-Tibet Plateau, the company utilizes high-quality local natural resources to manufacture products such as enoxolone, glycyrrhizic acid, and various glycyrrhizinate salts. Their manufacturing facilities are GMP-certified, and several of their products hold international certifications, including the European Certificate of Suitability (CEP). The company serves a global market across the pharmaceutical, cosmetic, and food industries, positioning itself as one of the world's leading suppliers of licorice extracts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qinghai Lake Pharmaceutical.